GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC

NCT06505486 · clinicaltrials.gov ↗

RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Intrahepatic Cholangiocarcinoma

Interventions

DRUG: Gemcitabine-Oxaliplatin Regimen

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University